{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "78206-147",
      "generic_name": "trastuzumab",
      "labeler_name": "Organon LLC",
      "brand_name": "Ontruzant",
      "active_ingredients": [
        {
          "name": "TRASTUZUMAB",
          "strength": "150 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "78206-147-01",
          "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (78206-147-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (78206-147-99)",
          "marketing_start_date": "20210601",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Organon LLC"
        ],
        "rxcui": [
          "2289227",
          "2289232",
          "2289234",
          "2289237"
        ],
        "spl_set_id": [
          "ce2a2492-85e3-4b0a-872a-047f44e4203d"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175661",
          "N0000020008"
        ],
        "pharm_class_epc": [
          "HER2/neu Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "HER2/Neu/cerbB2 Antagonists [MoA]"
        ],
        "unii": [
          "P188ANX8CK"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "9b665849-a59e-4da6-ae51-36b3c885b85b",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20210601",
      "product_id": "78206-147_9b665849-a59e-4da6-ae51-36b3c885b85b",
      "application_number": "BLA761100",
      "brand_name_base": "Ontruzant",
      "pharm_class": [
        "HER2/Neu/cerbB2 Antagonists [MoA]",
        "HER2/neu Receptor Antagonist [EPC]"
      ]
    }
  ]
}